본문 바로가기

Hepatic resection for isolated breast cancer liver metastasis: A single-center experience

문서 유형
연구출판물 · 학술지 논문
등재
KCI
저널
대한종양외과학회지13(2) · pp.108 · 2017
피인용
KCI 0
ISSN
1738-8082

저자

  1. 최재봉제1저자부산대학교, 의과대학, 의학과, KO
  2. 서형일교신저자부산대학교, 의과대학, 의학과, KO
  3. 윤성필부산대학교, 의과대학, 의학과, 외과학교실, KO
  4. 정영래부산대학교, 의과대학, 의학과, KO
  5. 이석원부산대학교, 의과대학, 의학과, KO
  6. 배영태부산대학교, 의과대학, 의학과, KO
  7. 김석부산대학교, 의과대학, 의학과, KO

초록

Purpose: The objective of this study was to investigate the outcomes of selected patients with breast cancer liver metastases (BCLM) without extrahepatic metastases after hepatic resection. Methods: Patients whose imaging findings did not show extrahepatic disease were selected for hepatic resection. If R0 resection was available and the operative risk was low in preoperative tests, the patients underwent surgery. Results: Between 2011 and 2014, six patients underwent hepatic resection for BCLM. All patients received hepatic resection to achieve an R0 resection. The time interval between initial detection of breast cancer and that of liver metastases in the patients, excluding one patient with synchronous metastases, was 55.2 months. Major liver resection was performed in four patients. Differences were observed in the hormone receptor status between the primary breast tumor and liver metastases; however, no difference was observed in the human epidermal growth factor receptor 2 status. The 1-year and 3-year overall survival rates after hepatic resection were 100% and 83.3%, respectively. The 1-year and 3-year disease free survival rates after hepatic resection were 66.7% and 50.0%, respectively. Conclusion: Curative resection may be considered as one of the multimodality treatments for BCLM. It shows benefit in selected patients; its selection criteria needs to be investigated.

키워드

Breast neoplasmsLiver metastasisLiver resectionPrognosis

식별자

KCI
ART002307521